Tobacco is usually discussed in relation to cancer, cardiovascular disease and lung disease. Its possible effects on fertility receive less attention, even though reproductive health is one of the areas covered by a new World Health Organization evidence summary.
The practical message is not that every person who smokes will experience infertility, or that tobacco is the only explanation when conception takes longer than expected. Fertility is influenced by age, reproductive conditions, genetics, medicines, environmental exposures and many other factors. The evidence does, however, support treating tobacco exposure as a modifiable risk that belongs in reproductive-health conversations.
What the WHO summary is designed to do
WHO published Tobacco and infertility on 28 October 2026 as part of its Tobacco Knowledge Summaries series. The document is intended to synthesize current evidence for health professionals, policymakers and advocates. It is an evidence summary, not an individual diagnosis or a promise that quitting will produce a particular fertility outcome.
That distinction matters. Population studies can show that tobacco exposure is associated with poorer reproductive outcomes, but they cannot determine the cause of infertility in one person. Individual assessment still requires a clinical history, appropriate testing and consideration of both partners.
How tobacco can affect reproductive health
Tobacco smoke contains nicotine and many combustion products that can affect blood vessels, inflammation and cellular function. In reproductive health, researchers examine several possible pathways: changes in sperm quality, effects on ovarian function, altered hormone signaling and damage caused by oxidative stress.
These mechanisms are biologically plausible, but plausibility is not the same as proof of a single pathway in every case. Human studies vary in design, exposure measurement and population. Some rely on self-reported smoking, while others use biomarkers. The strongest interpretation comes from the total pattern of evidence rather than one isolated result.
Exposure is not limited to cigarettes
Clinical conversations should ask about more than daily cigarette count. Second-hand smoke, smokeless tobacco, heated products and nicotine delivery can create different exposure patterns. Evidence is not equally mature for every product, and a product described as “smoke-free” should not automatically be treated as risk-free for fertility or pregnancy.
People may also change products while trying to quit. That can reduce exposure to combustion toxins in some circumstances, but it does not remove the need for evidence-based cessation support. A health professional can help match treatment to dependence, pregnancy plans, medicines and local guidance.
Seven responsible takeaways
- Include tobacco in fertility history. Ask about current use, past use, second-hand exposure and other nicotine products.
- Assess both partners. Fertility is a shared clinical question; focusing only on one partner can delay useful evaluation.
- Avoid deterministic language. Tobacco increases risk at the population level but does not prove why an individual is experiencing infertility.
- Offer cessation support early. A reproductive-health visit is an opportunity to discuss counseling, medicines and follow-up where appropriate.
- Do not wait for pregnancy. Risk reduction can begin before conception, when there is more time to plan support.
- Protect against second-hand smoke. Home and workplace exposure should be part of the conversation.
- Investigate other causes. Reducing tobacco exposure should complement, not replace, a complete fertility assessment.
What quitting can and cannot promise
Stopping tobacco use has broad health benefits and reduces exposure to toxins. It is reasonable to recommend cessation as part of preconception care. It is not responsible to guarantee that quitting will restore fertility or lead to pregnancy on a particular timeline.
Recovery may depend on the duration and intensity of exposure, age and other health factors. Some reproductive measures can change over time, while structural or unrelated causes require separate treatment. This is why cessation advice and fertility evaluation should proceed together when clinically indicated.
When to seek professional advice
People concerned about fertility should discuss timing with a qualified clinician, especially when there are known reproductive conditions, irregular cycles, previous pelvic surgery, sexual-function concerns or exposure to medicines and substances that may affect reproduction. Age also changes the recommended timing of evaluation.
The new WHO summary strengthens a clear public-health principle: reproductive care should not treat tobacco as an unrelated habit. It belongs in prevention, counseling and policy. But evidence should be communicated with precision—risk is not destiny, and a population association is not an individual diagnosis.
This article is for general information and does not replace personalized medical advice.
